{"pageContent": "Background: The primary treatments for clinically localized prostate cancer confer equivalent cancer control for most patients but disparate side effects. In the current study, the authors sought to compare health-related quality of life (HRQOL) outcomes after the most commonly used treatments.", "metaData": {"source": "Comparative evaluation of radiation treatments for clinically localized prostate cancer: an updated systematic review\nhttps://pubmed.ncbi.nlm.nih.gov/21646550/"}}